Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Shares Outstanding (2023 - 2025)

BrightSpring Health Services' Shares Outstanding history spans 3 years, with the latest figure at $192.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 10.26% year-over-year to $192.1 million; the TTM value through Dec 2025 reached $192.1 million, up 10.26%, while the annual FY2025 figure was $192.1 million, 10.26% up from the prior year.
  • Shares Outstanding reached $192.1 million in Q4 2025 per BTSG's latest filing, up from $180.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $192.1 million in Q4 2025 to a low of $117.9 million in Q3 2023.
  • Average Shares Outstanding over 3 years is $157.3 million, with a median of $172.7 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding: skyrocketed 47.85% in 2024, then increased 2.33% in 2025.
  • A 3-year view of Shares Outstanding shows it stood at $117.9 million in 2023, then surged by 47.85% to $174.2 million in 2024, then increased by 10.26% to $192.1 million in 2025.
  • Per Business Quant, the three most recent readings for BTSG's Shares Outstanding are $192.1 million (Q4 2025), $180.7 million (Q3 2025), and $177.1 million (Q2 2025).